The Role of the Acidity of N-Heteroaryl Sulfonamides as Inhibitors of Bcl-2 Family Protein-Protein Interactions

被引：52

作者：

Toure, B. Barry ^{[1
]}

Miller-Moslin, Karen ^{[1
]}

Yusuff, Naeem ^{[1
]}

Perez, Lawrence ^{[1
]}

Dore, Michael ^{[1
]}

Joud, Carol ^{[1
]}

Michael, Walter ^{[1
]}

DiPietro, Lucian ^{[1
]}

van der Plas, Simon ^{[1
]}

McEwan, Michael ^{[1
]}

Lenoir, Francois ^{[1
]}

Hoe, Madelene ^{[1
]}

Karki, Rajesh ^{[1
]}

Springer, Clayton ^{[1
]}

Sullivan, John ^{[1
]}

Levine, Kymberly ^{[1
]}

Fiorilla, Catherine ^{[1
]}

Xie, Xiaoling ^{[1
]}

Kulathila, Raviraj ^{[1
]}

Herlihy, Kara ^{[1
]}

Porter, Dale ^{[1
]}

Visser, Michael ^{[1
]}

机构：

[1] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2013年 / 4卷 / 02期

关键词：

B cell lymphoma; Bcl-2; family; protein-protein interaction; apoptosis; cancer; DISCOVERY; ANTAGONISTS; PRODRUGS;

D O I：

10.1021/ml300321d

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Overexpression of the antiapoptotic members of the Bcl-2 family of proteins is commonly associated with cancer cell survival and resistance to chemotherapeutics. Here, we describe the structure-based optimization of a series of N-heteroaryl sulfonamides that demonstrate potent mechanism-based cell death. The role of the acidic nature of the sulfonamide moiety as it relates to potency, solubility, and clearance is examined. This has led to the discovery of novel heterocyclic replacements for the acylsulfonamide core of ABT-737 and ABT-263.

引用

页码：186 / 190

页数：5

共 50 条

[31] Targeting Protein-Protein Interactions with Trimeric Ligands: High Affinity Inhibitors of the MAGUK Protein Family
Nissen, Klaus B.
Haugaard-Kedstrom, Linda M.
Wilbek, Theis S.
Nielsen, Line S.
Aberg, Emma
Kristensen, Anders S.
Bach, Anders
Jemth, Per
Stromgaard, Kristian
PLOS ONE, 2015, 10 (02):
[32] Small-molecule inhibitors of Bcl-2 protein
Pulley, H
Mohammad, R
DRUGS OF THE FUTURE, 2004, 29 (04) : 369 - 381
[33] Identification of the protein-protein contact site and interaction mode of human VDAC1 with Bcl-2 family proteins
Shi, Y
Chen, JJ
Weng, CJ
Chen, R
Zheng, YH
Chen, Q
Tang, H
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 305 (04) : 989 - 996
[34] Expression of bcl-2 family protein in forebrain ischemia
Kano, M
Okamura, K
BRAIN PATHOLOGY, 1997, 7 (04) : 1106 - 1106
[35] The Bcl-2 protein family: Arbiters of cell survival
Adams, JM
Cory, S
SCIENCE, 1998, 281 (5381) : 1322 - 1326
[36] New members of the Bcl-2 family and their protein partners
Farrow, SN
Brown, R
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (01) : 45 - 49
[37] Combination of Novel Imidazopyridazine Mps-1 Kinase Inhibitors and Bcl-2 Family Protein Inhibitors
Rosse, Gerard
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (01): : 7 - 8
[38] pH modulates kinetics of Bcl-2 family protein interactions and their association with membranes.
Xie, Z
Schendel, SL
Zha, H
Zhang, X
AimeSempe, C
Matsuyama, S
Reed, JC
BLOOD, 1997, 90 (10) : 222 - 222
[39] Bcl-2 family member Bcl-G is not a proapoptotic protein
M Giam
T Okamoto
J D Mintern
A Strasser
P Bouillet
Cell Death & Disease, 2012, 3 : e404 - e404
[40] Bcl-2 family member Bcl-G is not a proapoptotic protein
Giam, M.
Okamoto, T.
Mintern, J. D.
Strasser, A.
Bouillet, P.
CELL DEATH & DISEASE, 2012, 3 : e404 - e404

← 1 2 3 4 5 →